Medical policy
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…
Update history: LCD and article updates
View the most recent updates for our LCDs and articles. A new LCD has been posted for comment and another LCD and its related billing and coding article have been retired.
Update history: LCD and article updates
View the most recent updates for our LCDs and articles. A new LCD has been posted for comment and another LCD and its related billing and coding article have been retired.
Avoid negative impacts to your claims -- review billing and coding article A58918 molecular pathology and genetic testing
View this important information you must know if you bill for molecular pathology and genetic testing. This article was updated April 8.
Reporting the national drug code
Read this article for helpful information to report the national drug code on claims.
Prior authorization for ambulance transports is for repetitive transports
A repetitive service is defined as medically necessary ambulance transportation that is furnished three or more times during a 10-day period OR at least once per week for at least three weeks.…
Prior authorization for ambulance transports is for repetitive transports
A repetitive service is defined as medically necessary ambulance transportation that is furnished three or more times during a 10-day period OR at least once per week for at least three weeks.…